[Changes in the ascorbic acid content, dehydroascorbic acid and reduced glutathione in the brain of irradiated rats].
Explore the source record for details and available documents.
Animals↗
SEARCH · Search PubMed
Results for “Dehydroascorbic Acid”
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Ascorbic and dehydroascorbic acids measured in plasma preserved with dithiothreitol or metaphosphoric acid.
We describe a rapid method for accurately and precisely measuring ascorbic acid and dehydroascorbic acid in plasma. Total analysis time is less than 10 min, replicate analyses of a single pool provide precision less than or equal to 2%, and values measured in supplemented samples agree with known concentrations of 4.68 and 11.83 mg/L. The stability and homogeneity of lyophilized plasma samples supplemented with ascorbic acid and dithiothreitol are documented. We also describe a procedure in which metaphosphoric acid (50 g/L) is used to prepare a reference material for the measurement of ascorbic acid and dehydroascorbic acid. The procedure for both acids consists of first measuring the native ascorbic acid, then reducing the dehydroascorbic acid, at neutral pH, with dithiothreitol, and finally measuring the total ascorbic acid; dehydroascorbic acid is then determined by difference. The metaphosphoric-acid-treated samples were stable at -70 degrees C, but stability decreased with temperature over the range examined, 4-50 degrees C.
Ascorbic Acid↗
An improved method for determination of L-ascorbic acid and L-dehydroascorbic acid in blood plasma.
Various conditions for reducing L-dehydroascorbic acid were studied, using dithiothreitol. This led to an improved method for the separate determination of L-ascorbic acid and L-dehydroascorbic acid in blood plasma. The content of ascorbic acid was determined by an alpha,alpha'-dipyridyl method (A). Dehydroascorbic acid was reduced to ascorbic acid by incubation with dithiothreitol at room temperature for 10 min at pH 6.5 to 8.0. After removing the excess dithiothreitol with N-ethylmaleimide, total ascorbic acids, i.e. reduced plus original, were determined by the alpha,alpha'-dipyridyl method (B). The amount of dehydroascorbic acid could then be calculated from these results (B minus A).
2,2'-Dipyridyl↗
Blood dehydroascorbic acid and diabetes mellitus in human beings.
Ascorbic acid and dehydroascorbic acid were estimated in the blood of normal healthy subjects and diabetic patients. In normal subjects, blood contained only ascorbic acid while dehydroascorbic acid was practically absent. The ascorbic acid level was low in the blood of diabetic patients but the dehydroascorbic acid content was remarkably high, irrespective of age, sex, history of diabetes, or treatment. About 75% of blood dehydroascorbic acid was present in the erythrocytes: the rest was in plasma. High blood dehydroascorbic acid levels were also found in 90% of the non-diabetic offspring with both parents diabetic, in 24% of the non-diabetic offspring with one parent diabetic, and in 75% of the non-diabetic siblings of diabetic patients. It appears that, in persons having an hereditary predisposition to diabetes, high blood dehydroascorbic acid levels may be used as a marker for early detection of the disease.
Adolescent↗
Ascorbic and dehydroascorbic acid measurement in human serum and plasma.
Plasma supplemented with ascorbic acid was prepared; the stability of these samples was characterized and the accuracy of the supplementation was established. Studies on the accuracy, precision, and sources of methodological bias in the measurement of ascorbic acid were summarized. Measurements of the ratio of ascorbic acid to dehydroascorbic acid in clinical samples was evaluated and was shown to be relatively constant in plasma taken from blood stored at 12 degrees C for 6 h. These results imply that whole blood has the capacity to maintain a constant ascorbic-dehydroascorbic acid ratio and suggest that this ratio may be of physiological significance.
Ascorbic Acid↗
Uptake of L-ascorbic acid and L-dehydroascorbic acid by human erythrocytes and HeLa cells.
Uptake of AsA and DAsA by human cells, i.e., erythrocytes and HeLa cells, was examined in vitro. AsA was taken up very slowly, but DAsA was taken up very rapidly by erythrocytes to establish equilibrium after 1 minute. Uptake of the vitamins by HeLa cells was similar to that by erythrocytes, except there was an uptake of DAsA that reached saturation after 5 minutes. The DAsA taken up was reduced in part to AsA and the concentrations of DAsA inside and outside the cells became almost equal. GSH was responsible for this reduction. Although DAsA was evidently a more permeant form than AsA in the case of human cells, the relevance of this to the uptake of vitamin C by the tissues in vivo remains uncertain.
Ascorbic Acid↗
The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA).
Using a novel high performance liquid chromatography (HPLC) determination of ascorbic acid and dehydroascorbic acid, we have measured the relative amounts of ascorbate and dehydroascorbate in 20 normal controls and in paired sera and synovial fluid from 13 patients with rheumatoid arthritis (RA). In complete contrast to previous published findings we were able to detect dehydroascorbate in normal human sera (12.0 +/- 3.7 mumol/l), while the mean and range of ascorbate measured in normals was 69.6 +/- 20.6 mumol/l. These findings were completely reversed in rheumatoid sera (21.8 +/- 8.6 mumol/l and 5.1 +/- 5.0 mumol/l for dehydroascorbate and ascorbic acid respectively). In several rheumatoid sera no ascorbate could be detected. In paired synovial fluid and serum samples, there was always more dehydroascorbate detected in synovial fluids than in the corresponding sera (p less than 0.01). The data suggests that the reduced level of ascorbate and increased level of dehydroascorbate may be a reflection of the increased antioxidant and free-radical scavenging activity of the vitamin in RA, especially within the inflamed joint.
Adult↗
Use of homocysteine to stabilise ascorbic acid, or to reduce dehydroascorbic acid, during HPLC separation of large volumes of tissue extracts.
Explore the source record for details and available documents.
Ascorbic Acid↗
[Reduction of dehydroascorbic acid by thiols in presence of biocatalytic substances: polarographic study].
The chemical reduction of dehydroascorbic acid is studied in the presence of organic and vitaminic compounds. Redox properties of the compounds: ascorbic acid, dehydroascorbic acid, thiols such as glutathion, cistein, British anti-Lewisite (BAL), thiamin, riboflavin, para amino benzoic acid, biotin, 1-4 dihydronaphtoquinone and flavonoids (flavone and derived salts, quercetin rutin, 1-epicatechin and dimer) are established by direct and pulse polarography. The redox reactions are analysed by amperometry. From the results, it appears that the catalytic effect of biocatalyst of the dehydroascorbic reduction by thiols has no direct relation with the redox properties. This catalytic effect is specifically obtained with flavan-3 ol complex with antiscorbutic activities of C2 factor type.
Ascorbic Acid↗
Determination of dehydroascorbic acid using high-performance liquid chromatography with coulometric electrochemical detection.
A method for the detection of dehydroascorbic acid using high-performance liquid chromatography with coulometric electrochemical detection is described. Samples were first assayed for ascorbic acid, then reduced with 2,3-dimercapto-1-propanol to convert dehydroascorbic acid in the sample to ascorbic acid, and subsequently reassayed for total ascorbic acid. The dehydroascorbic acid content was the difference between the two measurements. The dehydroascorbic acid assay provides complete recovery of dehydroascorbic acid, without affecting the ascorbic acid content present prior to reduction. The assay is highly sensitive and reproducible with both standards and biological samples, and was used for routine detection of less than or equal to 1 pmol per sample injection of dehydroascorbic acid. Prior to reduction, dehydroascorbic acid standards frozen at -80 degrees C were stable for at least 1 month; after reduction, stability was limited to 3 days. Dehydroascorbic acid was added to human neutrophil samples; the samples were reduced and ascorbic acid was measured. Ascorbic acid in these samples was stable for greater than or equal to 12 h in a refrigerated autosampler (0-2 degrees C). With a run time for each sample of only 4 min, multiple samples can be prepared and placed in the autosampler for unattended assaying.
Chromatography, High Pressure Liquid↗
Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid.
We performed a detailed kinetic analysis of the uptake of dehydroascorbic acid by HL-60 cells under experimental conditions that enabled the differentiation of dehydroascorbic acid transport from the intracellular reduction/accumulation of ascorbic acid. Immunoblotting and immunolocalization experiments identified GLUT1 as the main glucose transporter expressed in the HL-60 cells. Kinetic analysis allowed the identification of a single functional activity involved in the transport of dehydroascorbic acid in the HL-60 cells. Transport was inhibited in a competitive manner by both 3-O-methyl-D-glucose and 2-deoxy-D-glucose. In turn, dehydroascorbic acid competitively inhibited the transport of both sugars. A second functional component identified in experiments measuring the accumulation of ascorbic acid appears to be associated with the intracellular reduction of dehydroascorbic acid to ascorbic acid and is not directly involved in the transport of dehydroascorbic acid via GLUT1. Transport of dehydroascorbic acid by HL-60 cells was independent of the presence of external Na+, whereas the intracellular accumulation of ascorbic acid was found to be a Na(+)-sensitive process. Thus, the transport of dehydroascorbic acid via glucose transporters is a Na(+)-independent process which is kinetically and biologically separable from the reduction of dehydroascorbic acid to ascorbic acid and its subsequent intracellular accumulation.
3-O-Methylglucose↗
Reinvestigation of the diabetogenic effect of dehydroascorbic acid.
To investigate the diabetogenic effect of pure dehydroascorbic acid, male Wister- and Sprague-Dawley rats received i.v. injections of the substance. No hyperglycemia and no decreased glucose tolerance were found. I.v. administration of the hydrolysis products of dehydroascorbic acid and of a solution containing monodehydroascorbate likewise did not increase blood glucose values. It is concluded that in previously performed experiments not dehydroascorbic acid itself but one or several impurities might have produced hyperglycemia in the rat. The electron transfer proteins tested (ascorbate:ferricytochrome b5 oxidoreductase, cytochrome b5, NADH:ferricytochrome b5 oxidoreductase, NADH:monodehydroascorbate oxidoreductase), which might participate in the reduction of dehydroascorbic acid, could not be induced in liver microsomes from Wistar rats by the injection of dehydroascorbic acid, its hydrolysis products, or monodehydroascorbate.
Animals↗
Ascorbic and dehydroascorbic acids simultaneously quantified in biological fluids by liquid chromatography with fluorescence detection, and comparison with a colorimetric assay.
We describe a "high-performance" liquid-chromatographic method for separating and quantifying ascorbic acid (AA) and dehydroascorbic acid (DHA) in plasma and urine. We used a reversed-phase C18 column with an ion-pair reagent and detected the analytes by post-column reaction with 4,5-dimethyl-o-phenylenediamine to form a fluorescent derivative (measured at excitation and emission wavelengths of 365 and 440 nm, respectively). Isoascorbic acid (IA) is the internal standard. Retention times for DHA, AA, and IA are 5.6, 15.5, and 19.9 min, respectively. Between-day CVs for AA in plasma in concentrations of 8 and 20 mg/L were 9% and 7%, respectively. The limit of detection is 10 and 4 ng for AA and DHA, respectively. Results by the present method and the methoxyaniline colorimetric method for AA are comparably accurate.
Ascorbic Acid↗
A highly sensitive high-performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in tissues, biological fluids, and foods.
A highly sensitive procedure for determining ascorbic acid (AA) and dehydroascorbic acid (DHAA) by high-performance liquid chromatography with electrochemical detection in biological fluids, tissues, and foods is described. AA is separated in a C18 reverse-phase column after extraction from the sample with metaphosphoric acid. An aliquot of 20 microliter of diluted extract is injected into the column for the estimation of AA. DHAA is indirectly estimated by converting it to AA after reduction with DL-homocysteine at pH 7.0-7.2 for 30 min at 25 degrees C. After dilution, a 20-microliter aliquot is injected into the column to obtain total vitamin C (AA + DHAA). The concentration of DHAA is calculated by subtraction. AA can be reproducibly quantified at concentrations as low as 50 pg/20 microliter of sample extract. The method described here used a specially designed mobile phase, gave greater stability and a noiseless baseline, and increased substantially the sensitivity and precision. The procedure is rapid, analysis being completed within 10 min after sample preparation, and has been successfully applied to biological fluids, tissues, and foods.
Animals↗
Spectrophotometric determination of dehydroascorbic acid in biological samples.
We describe a method for accurately and precisely measuring dehydroascorbic acid in perchloric acid extracts prepared from human plasma, lymphocytes, and mammalian cells. Samples were assayed by spectrophotometrically monitoring the kinetics of the concentration-dependent absorbance changes of dehydroascorbic acid with phosphate-methanol-containing buffers. The lowest detectable dehydroascorbate concentration using this assay is estimated to be below 0.1 mumol/liter. Total analysis time is less than 10 min and allows the simultaneous measurement of numerous samples. The calibration curve is linear (r > 0.995) over the range 0-200 mumol/liter. The dehydroascorbic acid concentrations measured in supplemented samples agree with known concentrations. Interference of ascorbic acid and 2,3-diketogulonic acid with this assay was excluded. The correlation with a highly specific chromatographic procedure gave comparable results over the range of physiologically relevant concentrations. The procedure avoids the most commonly applied method of measuring the native ascorbic acid, then reducing the dehydroascorbic acid, and finally measuring the total ascorbic acid and determining dehydroascorbic acid by the difference. Stabilization of ascorbic acid during assay was achieved by addition of desferrioxamine.
3T3 Cells↗
A specific high-performance liquid chromatography assay for dehydroascorbic acid shows an increased content in CLL lymphocytes.
A method for the assay of dehydroascorbic acid using high-performance liquid chromatography with uv detection is described. The dehydroascorbic acid is separated from ascorbic acid and reduced with dithiothreitol, and is then quantitated as ascorbic acid following rechromatography. Since as little as 22 pmol can be detected, sensitivity is at least 40-fold greater than that of other currently available procedures. This method was used to measure the level of dehydroascorbic acid in normal and chronic lymphocytic leukemia lymphocytes. A significantly higher concentration of dehydroascorbic acid was found in leukemic (21.80 +/- 3.55 nmol/10(8) cells, mean +/- SE) than in normal lymphocytes (9.32 +/- 1.15 nmol/10(8) cells) (P less than 0.03). Analysis of extracts from normal B cell lymphocytes revealed comparable dehydroascorbic acid levels to unfractionated lymphocytes, indicating that the elevated level in chronic lymphocytic leukemia was not simply a reflection of the increased percentage of B lymphocytes in this disorder. These studies illustrate that the technique can be used to measure the dehydroascorbic acid content from sources where only scanty material is available or low levels are found.
Ascorbic Acid↗
Accumulation of vitamin C (ascorbate) and its oxidized metabolite dehydroascorbic acid occurs by separate mechanisms.
It is unknown whether ascorbate alone (vitamin C), its oxidized metabolite dehydroascorbic acid alone, or both species are transported into human cells. This problem was addressed using specific assays for each compound, freshly synthesized pure dehydroascorbic acid, the specially synthesized analog 6-chloroascorbate, and a new assay for 6-chloroascorbate. Ascorbate and dehydroascorbic acid were transported and accumulated distinctly; neither competed with the other. Ascorbate was accumulated as ascorbate by sodium-dependent carrier-mediated active transport. Dehydroascorbic acid transport and accumulation as ascorbate was at least 10-fold faster than ascorbate transport and was sodium-independent. Once transported, dehydroascorbic acid was immediately reduced intracellularly to ascorbate. The analog 6-chloroascorbate had no effect on dehydroascorbic acid transport but was a competitive inhibitor of ascorbate transport. The Ki for 6-chloroascorbate (2.9-4.4 microM) was similar to the Km for ascorbate transport (9.8-12.6 microM). 6-Chloroascorbate was itself transported and accumulated in fibroblasts by a sodium-dependent transporter. These data provide new information that ascorbate and dehydroascorbic acid are transported into human neutrophils and fibroblasts by two distinct mechanisms and that the compound available for intracellular utilization is ascorbate.
Ascorbic Acid↗
Glucose-independent transport of dehydroascorbic acid in human erythrocytes.
It has been previously reported that glucose and its structural analogs inhibit dehydroascorbic acid (DHA) transport across the membranes of nonpolar cells, which led to the suggestion that the hexose transporter mediates dehydroascorbic acid transport. The present study examines the role of the erythrocyte hexose transport system in dehydroascorbic acid uptake. We have confirmed that dehydroascorbic acid may be a ligand of the hexose transport system under certain experimental conditions. However, there is an additional pathway of dehydroascorbic acid transport that is uninfluenced by external glucose. This pathway is one of facilitated diffusion, demonstrating saturation kinetics of transport, cis-inhibition, and trans-stimulation. The Km for the system is 412 microM. It is suggested that this previously undescribed sugar-independent transporter is the physiologically important route of DHA uptake in erythrocytes.
Adult↗